33 results on '"Podgorniak, Marie-Pierre"'
Search Results
2. EMMPRIN regulates β1 integrin-mediated adhesion through Kindlin-3 in human melanoma cells
- Author
-
Delyon, Julie, Khayati, Farah, Djaafri, Ibtissem, Podgorniak, Marie-Pierre, Sadoux, Aurélie, Setterblad, Niclas, Boutalbi, Zineb, Maouche, Kamel, Maskos, Uwe, Menashi, Suzanne, Lebbé, Céleste, and Mourah, Samia
- Published
- 2015
- Full Text
- View/download PDF
3. SIAH-1 interacts with CtIP and promotes its degradation by the proteasome pathway
- Author
-
Germani, Antonia, Prabel, Audrey, Mourah, Samia, Podgorniak, Marie-Pierre, Carlo, Anna Di, Ehrlich, Ricardo, Gisselbrecht, Sylvie, Varin-Blank, Nadine, Calvo, Fabien, and Bruzzoni-Giovanelli, Heriberto
- Published
- 2003
- Full Text
- View/download PDF
4. Identification of a novel biomarker signature associated with risk for bone metastasis in patients with renal cell carcinoma
- Author
-
paule, Bernard, Deslandes, emmanuelle, Le Mouel, stéphane E., Bastien, Laurence, podgorniak, Marie-pierre, allory, Yves, de la taille, alexandre, Menashi, Suzanne, Calvo, Fabien, and Mourah, samia
- Published
- 2010
5. Highly Sensitive Multivariable Assay Detection of Melanocytic Differentiation Antigens and Angiogenesis Biomarkers in Sentinel Lymph Nodes With Melanoma Micrometastases
- Author
-
Vitoux, Dominique, Mourah, Samia, Kerob, Delphine, Verola, Olivier, Basset-Seguin, Nicole, Baccard, Michel, Schartz, Noel, Ollivaud, Laurence, Archimbaud, Alain, Servant, Jean-Marie, Revol, Marc, Toubert, Marie-Elisabeth, Podgorniak, Marie-Pierre, Plassa, François, Porcher, Raphael, and Lebbé, Céleste
- Published
- 2009
- Full Text
- View/download PDF
6. Platelets, thrombospondin-1 and human dermal fibroblasts cooperate for stimulation of endothelial cell tubulogenesis through VEGF and PAI-1 regulation
- Author
-
Kellouche, Sabrina, Mourah, Samia, Bonnefoy, Arnaud, Schoëvaert, Damien, Podgorniak, Marie-Pierre, Calvo, Fabien, Hoylaerts, Marc F., Legrand, Chantal, and Dosquet, Christine
- Published
- 2007
- Full Text
- View/download PDF
7. Kaposi's Sarcoma-Associated Herpesvirus Viremia is Associated with the Progression of Classic and Endemic Kaposi's Sarcoma
- Author
-
Pellet, Claire, Kerob, Delphine, Dupuy, Alain, Carmagnat, Mary V., Mourah, Samia, Podgorniak, Marie-Pierre, Toledano, Cecile, Morel, Patrice, Vérola, Olivier, Dosquet, Christine, Hamel, Yamina, Calvo, Fabien, Rabian, Claire, and Lebbé, Céleste
- Published
- 2006
8. Distinct expression patterns of the E3 ligase SIAH-1 and its partner Kid/KIF22 in normal tissues and in the breast tumoral processes
- Author
-
Mourah Samia, Candeias Marco M, Powell Darren J, Podgorniak Marie-Pierre, Veiga Lucía, Fernandez Plinio, Bruzzoni-Giovanelli Heriberto, Calvo Fabien, and Marín Mónica
- Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract SIAH proteins are the human members of an highly conserved family of E3 ubiquitin ligases. Several data suggest that SIAH proteins may have a role in tumor suppression and apoptosis. Previously, we reported that SIAH-1 induces the degradation of Kid (KIF22), a chromokinesin protein implicated in the normal progression of mitosis and meiosis, by the ubiquitin proteasome pathway. In human breast cancer cells stably transfected with SIAH-1, Kid/KIF22 protein level was markedly reduced whereas, the Kid/KIF22 mRNA level was increased. This interaction has been further elucidated through analyzing SIAH and Kid/KIF22 expression in both paired normal and tumor tissues and cell lines. It was observed that SIAH-1 protein is widely expressed in different normal tissues, and in cells lines but showing some differences in western blotting profiles. Immunofluorescence microscopy shows that the intracellular distribution of SIAH-1 and Kid/KIF22 appears to be modified in human tumor tissues compared to normal controls. When mRNA expression of SIAH-1 and Kid/KIF22 was analyzed by real-time PCR in normal and cancer breast tissues from the same patient, a large variation in the number of mRNA copies was detected between the different samples. In most cases, SIAH-1 mRNA is decreased in tumor tissues compared to their normal counterparts. Interestingly, in all breast tumor tissues analyzed, variations in the Kid/KIF22 mRNA levels mirrored those seen with SIAH-1 mRNAs. This concerted variation of SIAH-1 and Kid/KIF22 messengers suggests the existence of an additional level of control than the previously described protein-protein interaction and protein stability regulation. Our observations also underline the need to re-evaluate the results of gene expression obtained by qRT-PCR and relate it to the protein expression and cellular localization when matched normal and tumoral tissues are analyzed.
- Published
- 2010
- Full Text
- View/download PDF
9. DETECTION OF CIRCULATING PSA-POSITIVE CELLS BY USING RT-PCR IN CLINICALLY LOCALIZED PROSTATE CANCER
- Author
-
Ravery, Vincent, de Crémoux, Patricia, Podgorniak, Marie-Pierre, Toublanc, Mariane, Boccon-Gibod, Liliane, and Boccon-Gibod, Laurent
- Published
- 1997
10. Clinical value of early detection of circulating tumour DNA-BRAFV600mut in patients with metastatic melanoma treated with a BRAF inhibitor
- Author
-
Louveau, Baptiste, Tost, Jörg, Mauger, Florence, Sadoux, Aurélie, Podgorniak, Marie-Pierre, How-Kit, Alexandre, Pages, Cécile, Roux, Jennifer, Da Meda, Laetitia, Lebbe, Céleste, and Mourah, Samia
- Published
- 2017
- Full Text
- View/download PDF
11. Discoidin domain receptors: A promising target in melanoma.
- Author
-
Reger de Moura, Coralie, Battistella, Maxime, Sohail, Anjum, Caudron, Anne, Feugeas, Jean Paul, Podgorniak, Marie‐Pierre, Pages, Cecile, Mazouz Dorval, Sarra, Marco, Oren, Menashi, Suzanne, Fridman, Rafael, Lebbé, Celeste, Mourah, Samia, and Jouenne, Fanélie
- Subjects
SMALL interfering RNA ,MELANOMA ,PROTEIN-tyrosine kinases ,MICROPHTHALMIA-associated transcription factor ,IMMUNOSTAINING ,BRAF genes ,DISCOIDIN domain receptors - Abstract
The discoidin domain receptor 1 (DDR1) is a member of the receptor tyrosine kinase family that signals in response to collagen and that has been implicated in cancer progression. In the present study, we investigated the expression and role of DDR1 in human melanoma progression. Immunohistochemical staining of human melanoma specimens (n = 52) shows high DDR1 expression in melanoma lesions that correlates with poor prognosis. DDR1 expression was associated with the clinical characteristics of Clark level and ulceration and with BRAF mutations. Downregulation of DDR1 by small interfering RNA (siRNA) in vitro inhibited melanoma cells malignant properties, migration, invasion, and survival in several human melanoma cell lines. A DDR tyrosine kinase inhibitor (DDR1‐IN‐1) significantly inhibited melanoma cell proliferation in vitro, and ex vivo and in tumor xenografts, underlining the promising potential of DDR1 inhibition in melanoma. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
12. EMMPRIN/CD147 is an independent prognostic biomarker in cutaneous melanoma.
- Author
-
Caudron, Anne, Battistella, Maxime, Feugeas, Jean‐Paul, Pages, Cécile, Basset‐Seguin, Nicole, Mazouz Dorval, Sarra, Funck Brentano, Elisa, Sadoux, Aurélie, Podgorniak, Marie‐Pierre, Menashi, Suzanne, Janin, Anne, Lebbé, Céleste, and Mourah, Samia
- Subjects
SKIN cancer ,MELANOMA prognosis ,CD antigens ,BIOMARKERS ,IMMUNOHISTOCHEMISTRY ,BRAF genes ,RAS oncogenes ,PROGNOSIS - Abstract
CD147 has been implicated in melanoma invasion and metastasis mainly through increasing metalloproteinase synthesis and regulating VEGF/ VEGFR signalling. In this study, the prognostic value of CD147 expression was investigated in a cohort of 196 cutaneous melanomas including 136 consecutive primary malignant melanomas, 30 lymph nodes, 16 in-transit and 14 visceral metastases. A series of 10 normal skin, 10 blue nevi and 10 dermal nevi was used as control. CD147 expression was assessed by immunohistochemistry, and the association of its expression with the clinicopathological characteristics of patients and survival was evaluated using univariate and multivariate statistical analyses. Univariate analysis showed that high CD147 expression was significantly associated with metastatic potential and with a reduced overall survival ( P < 0.05 for both) in primary melanoma patients. CD147 expression level was correlated with histological factors which were associated with prognosis: Clark level, ulceration status and more particularly with Breslow index ( r = 0.7, P < 10
−8 ). Multivariate analysis retained CD147 expression level and ulceration status as predicting factors for metastasis and overall survival ( P < 0.05 for both). CD147 emerges as an important factor in the aggressive behaviour of melanoma and deserves further evaluation as an independent prognostic biomarker. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
13. BRAFV600 mutation levels predict response to vemurafenib in metastatic melanoma.
- Author
-
Lebbé, Celeste, How-Kit, Alexandre, Battistella, Maxime, Sadoux, Aurelie, Podgorniak, Marie-Pierre, Sidina, Irina, Pages, Cécile, Roux, Jennifer, Porcher, Raphael, Tost, Jorg, and Mourah, Samia
- Published
- 2014
- Full Text
- View/download PDF
14. A Reliable Method for the Selection of Exploitable Melanoma Archival Paraffin Embedded Tissues for Transcript Biomarker Profiling.
- Author
-
Lebbe, Celeste, Guedj, Mickael, Basset-Seguin, Nicole, Podgorniak, Marie Pierre, Menashi, Suzanne, Janin, Anne, and Mourah, Samia
- Subjects
MELANOMA ,BIOMARKERS ,MESSENGER RNA ,GENE expression ,ALKANES ,FORMALDEHYDE - Abstract
The source tissue for biomarkers mRNA expression profiling of tumors has traditionally been fresh-frozen tissue. The adaptation of formalin-fixed, paraffin-embedded (FFPE) tissues for routine mRNA profiling would however be invaluable in view of their abundance and the clinical information related to them. However, their use in the clinic remains a challenge due to the poor quality of RNA extracted from such tissues. Here, we developed a method for the selection of melanoma archival paraffin-embedded tissues that can be reliably used for transcript biomarker profiling. For that, we used qRT-PCR to conduct a comparative study in matched pairs of frozen and FFPE melanoma tissues of the expression of 25 genes involved in angiogenesis/tumor invasion and 15 housekeeping genes. A classification method was developed that can select the samples with a good frozen/FFPE correlation and identify those that should be discarded on the basis of paraffin data for four reference genes only. We propose therefore a simple and inexpensive assay which improves reliability of mRNA profiling in FFPE samples by allowing the identification and analysis of ''good'' samples only. This assay which can be extended to other genes would however need validation at the clinical level and on independent tumor series. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
15. Invading Basement Membrane Matrix Is Sufficient for MDA-MB-231 Breast Cancer Cells to Develop a Stable In Vivo Metastatic Phenotype.
- Author
-
Abdelkarim, Mohamed, Vintonenko, Nadejda, Starzec, Anna, Robles, Aniela, Aubert, Julie, Martin, Marie-Laure, Mourah, Samia, Podgorniak, Marie-Pierre, Rodrigues-Ferreira, Sylvie, Nahmias, Clara, Couraud, Pierre-Olivier, Doliger, Christelle, Sainte-Catherine, Odile, Peyri, Nicole, Lei Chen, Mariau, Jérémie, Etienne, Monique, Perret, Gerard-Yves, Crepin, Michel, and Poyet, Jean-Luc
- Subjects
BREAST cancer ,CANCER cell proliferation ,GENOTYPE-environment interaction ,NUDE mouse ,LABORATORY mice ,CANCER invasiveness ,CELL adhesion molecules ,CELL death ,CELL membranes ,GENETIC polymorphisms - Abstract
Introduction: The poor efficacy of various anti-cancer treatments against metastatic cells has focused attention on the role of tumor microenvironment in cancer progression. To understand the contribution of the extracellular matrix (ECM) environment to this phenomenon, we isolated ECM surrogate invading cell populations from MDA-MB-231 breast cancer cells and studied their genotype and malignant phenotype. Methods: We isolated invasive subpopulations (INV) from non invasive populations (REF) using a 2D-Matrigel assay, a surrogate of basal membrane passage. INV and REF populations were investigated by microarray assay and for their capacities to adhere, invade and transmigrate in vitro, and to form metastases in nude mice. Results: REF and INV subpopulations were stable in culture and present different transcriptome profiles. INV cells were characterized by reduced expression of cell adhesion and cell-cell junction genes (44% of down regulated genes) and by a gain in expression of anti-apoptotic and pro-angiogenic gene sets. In line with this observation, in vitro INV cells showed reduced adhesion and increased motility through endothelial monolayers and fibronectin. When injected into the circulation, INV cells induced metastases formation, and reduced injected mice survival by up to 80% as compared to REF cells. In nude mice, INV xenografts grew rapidly inducing vessel formation and displaying resistance to apoptosis. Conclusion: Our findings reveal that the in vitro ECM microenvironment per se was sufficient to select for tumor cells with a stable metastatic phenotype in vivo characterized by loss of adhesion molecules expression and induction of proangiogenic and survival factors. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
16. EMMPRIN Promotes Melanoma Cells Malignant Properties through a HIF-2alpha Mediated Up-Regulation of VEGF-Receptor-2.
- Author
-
Bougatef, Faten, Menashi, Suzanne, Khayati, Farah, Naïmi, Benyoussef, Porcher, Raphaël, Podgorniak, Marie-Pierre, Millot, Guy, Janin, Anne, Calvo, Fabien, Lebbé, Céleste, and Mourah, Samia
- Subjects
MELANOMA ,CELL lines ,CELL proliferation ,APOPTOSIS ,CANCER invasiveness ,CELL growth ,NEOVASCULARIZATION ,PROTEIN kinases ,GENE expression ,GENETIC regulation - Abstract
EMMPRIN's expression in melanoma tissue was reported to be predictive of poor prognosis. Here we demonstrate that EMMPRIN up-regulated VEGF receptor-2 (VEGFR-2) in two different primary melanoma cell lines and consequently increased migration and proliferation of these cells while inhibiting their apoptosis. SiRNA inhibition of VEGFR-2 expression abrogated these EMMPRIN effects. EMMPRIN regulation of VEGFR-2 was mediated through the over-expression of HIF-2α and its translocation to the nucleus where it forms heterodimers with HIF-1β. These results were supported by an in vivo correlation between the expression of EMMPRIN with that of VEGFR-2 in human melanoma tissues as well as with the extent of HIF-2α localization in the nucleus. They demonstrate a novel mechanism by which EMMPRIN promotes tumor progression through HIF-2α/VEGFR-2 mediated mechanism, with an autocrine role in melanoma cell malignancy. The inhibition of EMMPRIN in cancer may thus simultaneously target both the VEGFR-2/VEGF system and the matrix degrading proteases to block tumor cell growth and invasion. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
17. Soluble Isoforms of Vascular Endothelial Growth Factor Are Predictors of Response to Sunitinib in Metastatic Renal Cell Carcinomas.
- Author
-
Paule, Bernard, Bastien, Laurence, Deslandes, Emmanuelle, Cussenot, Olivier, Podgorniak, Marie-Pierre, Allory, Yves, Naïmi, Benyoussef, Porcher, Raphael, de La Taille, Alexandre, Menashi, Suzanne, Calvo, Fabien, and Mourah, Samia
- Subjects
VASCULAR endothelial growth factors ,CANCER treatment ,RENAL cell carcinoma ,PROTEIN-tyrosine kinase inhibitors ,NEOVASCULARIZATION ,BIOMARKERS ,PATIENT selection ,POLYMERASE chain reaction ,THERAPEUTICS - Abstract
Background: Angiogenesis is the target of several agents in the treatment of malignancies, including renal cell carcinoma (RCC). There is a real need for surrogate biomarkers that can predict selection of patients who may benefit from antiangiogenic therapies, prediction of disease outcome and which may improve the knowledge regarding mechanism of action of these treatments. Tyrosine kinase inhibitors (TKI) have proven efficacy in metastatic RCC (mRCC). However, the molecular mechanisms underlying the clinical response to these drugs remain unclear. Methodology/Principal Findings: The present study aimed to identify molecular biomarkers associated with the response to sunitinib, a Tyrosine kinase inhibitor. To evaluate this relationship, primary tumors from 23 metastatic RCC patients treated by sunitinib were analyzed for a panel of 16 biomarkers involved in tumor pathways targeted by sunitinib, using real-time quantitative reverse-transcriptase PCR. Nine of the 23 patients (39%) responded to sunitinib. Among transcripts analyzed, only the levels of vascular endothelial growth factor (VEGF) soluble isoforms (VEGF
121 and VEGF165 ) were associated with the response to sunitinib (P = 0.04 for both). Furthermore, the ratio of VEGF soluble isoforms (VEGF121 / VEGF165 ) was significantly associated with prognosis (P = 0.02). Conclusions: This preliminary study provides a promising tool that might help in the management of metastatic RCC, and could be extended to other tumors treated by TKI. [ABSTRACT FROM AUTHOR]- Published
- 2010
- Full Text
- View/download PDF
18. Inhibition of the Proprotein Convertases Represses the Invasiveness of Human Primary Melanoma Cells with Altered p53, CDKN2A and N-Ras Genes.
- Author
-
Lalou, Claude, Scamuffa, Nathalie, Mourah, Samia, Plassa, Francois, Podgorniak, Marie-Pierre, Soufir, Nadem, Dumaz, Nicolas, Calvo, Fabien, Basset-Seguin, Nicole, and Khatib, Abdel-Majid
- Abstract
Background: Altered tumor suppressor p53 and/or CDKN2A as well as Ras genes are frequently found in primary and metastatic melanomas. These alterations were found to be responsible for acquisition of invasive and metastatic potential through their defective regulatory control of metalloproteinases and urokinase genes. Methodology/Principal Findings: Using primary human melanoma M10 cells with altered p53, CDKN2A and N-Ras genes, we found that inhibition of the proprotein convertases (PCs), enzymes involved in the proteolytic activation of various cancer-related protein precursors resulted in significantly reduced invasiveness. Analysis of M10 cells and their gastric and lymph node derived metastatic cells revealed the presence of all the PCs found in the secretory pathway. Expression of the general PCs inhibitor α1-PDX in these cells in a stable manner (M10/PDX) had no effect on the mRNA expression levels of these PCs. Whereas, in vitro digestion assays and cell transfection experiments, revealed that M10/PDX cells display reduced PCs activity and are unable to process the PCs substrates proIGF-1R and proPDGF-A. These cells showed reduced migration and invasion that paralleled decreased gelatinase MMP-2 activity and increased expression and secretion of tissue inhibitor of metalloproteinase-1 (TIMP-1) and TIMP-2. Furthermore, these cells showed decreased levels of urokinase-type plasminogen activator receptor (uPAR) and increased levels of plasminogen activator inhibitor-1 (PAI-1). Conclusions: Taken together, these data suggest that inhibition of PCs activity results in decreased invasiveness of primary human melanoma cells despite their altered p53, CDKN2A and N-Ras genes, suggesting that PCs may serve as novel therapeutic targets in melanoma. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
19. Distinct expression patterns of the E3 ligaseSIAH-1 and its partner Kid/KIF22 in normaltissues and in the breast tumoral processes.
- Author
-
Bruzzoni-Giovanelli, Heriberto, Fernandez, Plinio, Veiga, Lucía, Podgorniak, Marie-Pierre, Powell, Darren J., Candeias, Marco M., Mourah, Samia, Calvo, Fabien, and Marín, Mónica
- Subjects
BREAST cancer ,UBIQUITIN ,LIGASES ,APOPTOSIS ,GENE expression ,MITOSIS ,MEIOSIS ,CELL lines ,IMMUNOFLUORESCENCE - Abstract
SIAH proteins are the human members of an highly conserved family of E3 ubiquitin ligases. Several data suggest that SIAH proteins may have a role in tumor suppression and apoptosis. Previously, we reported that SIAH-1 induces the degradation of Kid (KIF22), a chromokinesin protein implicated in the normal progression of mitosis and meiosis, by the ubiquitin proteasome pathway. In human breast cancer cells stably transfected with SIAH-1, Kid/KIF22 protein level was markedly reduced whereas, the Kid/KIF22 mRNA level was increased. This interaction has been further elucidated through analyzing SIAH and Kid/KIF22 expression in both paired normal and tumor tissues and cell lines. It was observed that SIAH-1 protein is widely expressed in different normal tissues, and in cells lines but showing some differences in western blotting profiles. Immunofluorescence microscopy shows that the intracellular distribution of SIAH-1 and Kid/KIF22 appears to be modified in human tumor tissues compared to normal controls. When mRNA expression of SIAH-1 and Kid/KIF22 was analyzed by real-time PCR in normal and cancer breast tissues from the same patient, a large variation in the number of mRNA copies was detected between the different samples. In most cases, SIAH-1 mRNA is decreased in tumor tissues compared to their normal counterparts. Interestingly, in all breast tumor tissues analyzed, variations in the Kid/KIF22 mRNA levels mirrored those seen with SIAH-1 mRNAs. This concerted variation of SIAH-1 and Kid/KIF22 messengers suggests the existence of an additional level of control than the previously described protein-protein interaction and protein stability regulation. Our observations also underline the need to re-evaluate the results of gene expression obtained by qRT-PCR and relate it to the protein expression and cellular localization when matched normal and tumoral tissues are analyzed. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
20. Quantification of VEGF isoforms and VEGFR transcripts by qRT-PCR and their significance in acute myeloid leukemia.
- Author
-
Mourah, Samia, Porcher, Raphaël, Lescaille, Géraldine, Rousselot, Philippe, Podgorniak, Marie-Pierre, Labarchède, Géraldine, Naïmi, Benyoussef, Medioni, Jacques, Dombret, Hervé, and Calvo, Fabien
- Published
- 2009
- Full Text
- View/download PDF
21. Driver KIT mutations in melanoma cluster in four hotspots.
- Author
-
Dumaz, Nicolas, André, Jocelyne, Sadoux, Aurélie, Laugier, Florence, Podgorniak, Marie Pierre, Mourah, Samia, and Lebbé, Céleste
- Published
- 2015
- Full Text
- View/download PDF
22. Estramustine resistance correlates with tau over-expression in human prostatic carcinoma cells.
- Author
-
Sangrajrang, Suleeporn, Denoulet, Philippe, Millot, Guy, Tatoud, Roger, Podgorniak, Marie-Pierre, Tew, Kenneth D., Calvo, Fabien, and Fellous, Arlette
- Published
- 1998
- Full Text
- View/download PDF
23. Stromal cells from human benign prostate hyperplasia produce a growth-inhibitory factor for LNCaP prostate cancer cells, identified as interleukin-6.
- Author
-
Degeorges, Armelle, Tatoud, Roger, Fauvel-Lafeve, Françoise, Podgorniak, Marie-Pierre, Millot, Guy, de Cremoux, Patricia, and Calvo, Fabien
- Published
- 1996
- Full Text
- View/download PDF
24. Epstein-Barr Virus (EBV) Genome and Expression in Breast Cancer Tissue: Effect of EBV Infection of Breast Cancer Cells on Resistance to Paclitaxel (Taxol).
- Author
-
Arbach, Hratch, Viglasky, Viktor, Lefeu, Florence, Guinebretiëre, Jean-Marc, Ramirez, Vanessa, Bride, Nadëge, Boualaga, Nadia, Bauchet, Thomas, Peyrat, Jean-Philippe, Mathieu, Marie-Christine, Mourah, Samia, Podgorniak, Marie-Pierre, Seignerin, Jean-Marie, Takada, Kenzo, and Joab, Irène
- Subjects
- *
EPSTEIN-Barr virus , *BREAST cancer , *CANCER cells , *PACLITAXEL , *DRUG resistance in cancer cells , *CANCER treatment , *CANCER genetics , *DRUG efficacy - Abstract
The Epstein-Barr virus (EBV) has been detected in subsets of breast cancers. In order to elaborate on these observations, we quantified by real-time PCR (Q-PCR) the EBV genome in biopsy specimens of breast cancer tissue as well as in tumor cells isolated by microdissection. Our findings show that EBV genomes can be detected by Q-PCR in about half of tumor specimens, usually in low copy numbers. However, we also found that the viral load is highly variable from tumor to tumor. Moreover, EBV genomes are heterogeneously distributed in morphologically identical tumor cells, with some clusters of isolated tumor cells containing relatively high genome numbers while other tumor cells isolated from the same specimen may be negative for EBV DNA. Using reverse transcription-PCR, we detected EBV gene transcripts: EBNA-1 in almost all of the EBV-positive tumors and RNA of the EBV oncoprotein LMP-1 in a smaller subset of the tissues analyzed. Moreover, BARF-1 RNA was detected in half of the cases studied. Furthermore, we observed that in vitro EBV infection of breast carcinoma cells confers resistance to paclitaxel (taxol) and provokes overexpression of a multidrug resistance gene (MDR1). Consequently, even if a small number of breast cancer cells are EBV infected, the impact of EBV infection on the efficiency of anticancer treatment might be of importance. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
25. A targeted genomic alteration analysis predicts survival of melanoma patients under BRAF inhibitors.
- Author
-
Louveau B, Delyon J, De Moura CR, Battistella M, Jouenne F, Golmard L, Sadoux A, Podgorniak MP, Chami I, Marco O, Caramel J, Dalle S, Feugeas JP, Dumaz N, Lebbe C, and Mourah S
- Abstract
Several mechanisms have been described to elucidate the emergence of resistance to MAPK inhibitors in melanoma and there is a crucial need for biomarkers to identify patients who are likely to achieve a better and long-lasting response to BRAF inhibitors therapy. In this study, we developed a targeted approach combining both mRNA and DNA alterations analysis focusing on relevant gene alterations involved in acquired BRAF inhibitor resistance. We collected baseline tumor samples from 64 melanoma patients at BRAF inhibitor treatment initiation and showed that the presence, prior to treatment, of mRNA over-expression of genes' subset was significantly associated with improved progression free survival and overall survival. The presence of DNA alterations was in favor of better overall survival. The genomic analysis of relapsed-matched tumor samples from 20 patients allowed us to uncover the largest landscape of resistance mechanisms reported to date as at least one resistance mechanism was identified for each patient studied. Alterations in RB1 have been most frequent and hence represent an important additional acquired resistance mechanism. Our targeted genomic analysis emerges as a relevant tool in clinical practice to identify those patients who are more likely to achieve durable response to targeted therapies and to exhaustively describe the spectrum of resistance mechanisms. Our approach can be adapted to new targeted therapies by including newly identified genetic alterations., Competing Interests: CONFLICTS OF INTEREST BL, JD, CRdM, LG, FJ, AS, MPP, IC, OM, JC, JPF and ND have no conflicts of interest to declare. MB declares a consulting role for Histalim, Bristol-Myers Squibb, and Innate Pharma. SD is a principal investigator in studies conducted by Roche-Genentech and Novartis. CL declares honoraria from Roche, advisory roles at Roche, GSK, Novartis, BMS, MSD, and Amgen and travel accommodation provided by Roche. SM declares a consulting role at Roche, Janssen and Novartis.
- Published
- 2019
- Full Text
- View/download PDF
26. Correction: Validation of a preclinical model for assessment of drug efficacy in melanoma.
- Author
-
Delyon J, Varna M, Feugeas JP, Sadoux A, Yahiaoui S, Podgorniak MP, Leclert G, Mazouz Dorval S, Dumaz N, Janin A, Mourah S, and Lebbé C
- Published
- 2016
- Full Text
- View/download PDF
27. Validation of a preclinical model for assessment of drug efficacy in melanoma.
- Author
-
Delyon J, Varna M, Feugeas JP, Sadoux A, Yahiaoui S, Podgorniak MP, Leclert G, Dorval SM, Dumaz N, Soulie, Janin A, Mourah S, and Lebbé C
- Subjects
- Animals, Humans, Mice, Antineoplastic Agents pharmacology, Drug Screening Assays, Antitumor methods, Melanoma drug therapy, Melanoma genetics, Xenograft Model Antitumor Assays methods
- Abstract
The aim of personalized medicine is to improve our understanding of the disease at molecular level and to optimize therapeutic management. In this context, we have developed in vivo and ex vivo preclinical strategies evaluating the efficacy of innovative drugs in melanomas. Human melanomas (n = 17) of different genotypes (mutated BRAF, NRAS, amplified cKIT and wild type) were successfully engrafted in mice then amplified by successive transplantations. The exhaustive characterization of patient-derived xenografts (PDX) at genomic level (transcriptomic and CGH arrays) revealed a similar distribution pattern of genetic abnormalities throughout the successive transplantations compared to the initial patient tumor, enabling their use for mutation-specific therapy strategies. The reproducibility of their spontaneous metastatic potential in mice was assessed in 8 models. These PDXs were used for the development of histoculture drug response assays (ex vivo) for the evaluation of innovative drug efficacy (BRAF and MEK inhibitors). The pharmacological effects of BRAF and MEK inhibitors were similar between PDX-derived histocultures and their corresponding PDX, on 2 models of BRAF and NRAS-mutated melanomas. These models constitute a validated, effective tool for preclinical investigation of new therapeutic agents, and improve therapeutic strategies in the treatment of metastatic melanoma.
- Published
- 2016
- Full Text
- View/download PDF
28. EMMPRIN/CD147 is a novel coreceptor of VEGFR-2 mediating its activation by VEGF.
- Author
-
Khayati F, Pérez-Cano L, Maouche K, Sadoux A, Boutalbi Z, Podgorniak MP, Maskos U, Setterblad N, Janin A, Calvo F, Lebbé C, Menashi S, Fernandez-Recio J, and Mourah S
- Subjects
- Angiogenesis Inhibitors chemistry, Animals, Binding Sites, Cell Line, Cell Line, Tumor, Cell Membrane metabolism, Cell Movement, Cell-Free System, Computer Simulation, Female, Gene Silencing, Humans, Ligands, Mice, Mice, Nude, Microvessels cytology, Mutagenesis, Mutagenesis, Site-Directed, Neoplasm Transplantation, Neovascularization, Pathologic, Phosphorylation, Protein Binding, Protein Structure, Tertiary, RNA, Small Interfering metabolism, Recombinant Proteins metabolism, Signal Transduction, Basigin metabolism, Gene Expression Regulation, Neoplastic, Vascular Endothelial Growth Factor A metabolism, Vascular Endothelial Growth Factor Receptor-2 metabolism
- Abstract
EMMPRIN/CD147 is mainly known for its protease inducing function but a role in promoting tumor angiogenesis has also been demonstrated. This study provides evidence that EMMPRIN is a new coreceptor for the VEGFR-2 tyrosine kinase receptor in both endothelial and tumor cells, as it directly interacts with it and regulates its activation by its VEGF ligand, signalling and functional consequences both in vitro and in vivo. Computational docking analyses and mutagenesis studies identified a molecular binding site in the extracellular domain of EMMPRIN located close to the cell membrane and containing the amino acids 195/199. EMMPRIN is overexpressed in cancer and hence is able to further potentiate VEGFR-2 activation, suggesting that a combinatory therapy of an antiangiogenic drug together with an inhibitor of EMMPRIN/VEGFR-2 interaction may have a greater impact on inhibiting angiogenesis and malignancy.
- Published
- 2015
- Full Text
- View/download PDF
29. A novel tumor suppressor function of Kindlin-3 in solid cancer.
- Author
-
Djaafri I, Khayati F, Menashi S, Tost J, Podgorniak MP, Sadoux A, Daunay A, Teixeira L, Soulier J, Idbaih A, Setterblad N, Fauvel F, Calvo F, Janin A, Lebbé C, and Mourah S
- Subjects
- Animals, Azacitidine analogs & derivatives, Azacitidine pharmacology, Breast Neoplasms drug therapy, Breast Neoplasms genetics, Cell Adhesion genetics, Cell Line, Tumor, Cell Proliferation genetics, DNA Methylation, Decitabine, Female, Gene Expression Regulation, Neoplastic, Heterografts, Humans, Integrin beta3 metabolism, Melanoma drug therapy, Melanoma genetics, Membrane Proteins biosynthesis, Membrane Proteins metabolism, Mice, Neoplasm Invasiveness genetics, Neoplasm Metastasis genetics, Neoplasm Proteins biosynthesis, Neoplasm Proteins metabolism, Neoplasm Transplantation, Phosphorylation, RNA Interference, RNA, Messenger biosynthesis, RNA, Small Interfering, Talin genetics, Breast Neoplasms pathology, Genes, Tumor Suppressor, Melanoma pathology, Membrane Proteins genetics, Neoplasm Proteins genetics
- Abstract
Kindlin-3 (FERMT-3) is known to be central in hemostasis and thrombosis control and its deficiency disrupts platelet aggregation and causes Leukocyte Adhesion Deficiency disease. Here we report that Kindlin-3 has a tumor suppressive role in solid cancer. Our present genetic and functional data show that Kindlin-3 is downregulated in several solid tumors by a mechanism involving gene hypermethylation and deletions. In vivo experiments demonstrated that Kindlin-3 knockdown in 2 tumor cell models (breast cancer and melanoma) markedly increases metastasis formation, in accord with the in vitro increase of tumor cell malignant properties. The metastatic phenotype was supported by a mechanism involving alteration in β3-integrin activation including decreased phosphorylation, interaction with talin and the internalization of its active form leading to less cell attachment and more migration/invasion. These data uncover a novel and unexpected tumor suppressor role of Kindlin-3 which can influence integrins targeted therapies development.
- Published
- 2014
- Full Text
- View/download PDF
30. BRAF(V600) mutation levels predict response to vemurafenib in metastatic melanoma.
- Author
-
Lebbé C, How-Kit A, Battistella M, Sadoux A, Podgorniak MP, Sidina I, Pages C, Roux J, Porcher R, Tost J, and Mourah S
- Subjects
- Antineoplastic Agents adverse effects, Disease Progression, Female, Humans, Indoles adverse effects, Male, Melanoma enzymology, Melanoma genetics, Neoplasm Metastasis, Proto-Oncogene Proteins B-raf metabolism, Skin Neoplasms enzymology, Skin Neoplasms genetics, Sulfonamides adverse effects, Treatment Outcome, Vemurafenib, Antineoplastic Agents therapeutic use, Indoles therapeutic use, Melanoma drug therapy, Mutation, Proto-Oncogene Proteins B-raf genetics, Skin Neoplasms drug therapy, Sulfonamides therapeutic use
- Published
- 2014
- Full Text
- View/download PDF
31. EMMPRIN/CD147 up-regulates urokinase-type plasminogen activator: implications in oral tumor progression.
- Author
-
Lescaille G, Menashi S, Cavelier-Balloy B, Khayati F, Quemener C, Podgorniak MP, Naïmi B, Calvo F, Lebbe C, and Mourah S
- Subjects
- Blotting, Western, Carcinoma, Squamous Cell pathology, Cell Line, Tumor, Cell Movement physiology, Disease Progression, Humans, Immunohistochemistry, Mouth Neoplasms pathology, Neoplasm Invasiveness pathology, Precancerous Conditions metabolism, Real-Time Polymerase Chain Reaction, Up-Regulation, Basigin physiology, Carcinoma, Squamous Cell metabolism, Mouth Neoplasms metabolism, Neoplasm Proteins physiology, Urokinase-Type Plasminogen Activator metabolism
- Abstract
Backgrounds: An elevated level of EMMPRIN in cancer tissues have been correlated with tumor invasion in numerous cancers including oral cavity and larynx. Although EMMPRIN's effect has been generally attributed to its MMP inducing activity, we have previously demonstrated in breast cancer model that EMMPRIN can also enhance invasion by upregulating uPA. In this study, the role of EMMPRIN in regulating uPA and invasion was investigated in oral squamous cell carcinoma (OSCC) progression., Methods: Precancerous and invasive oral tumoral tissues were used as well as the corresponding cell lines, DOK and SCC-9 respectively. The paracrine regulation of uPA by EMMPRIN was investigated by treating culture cells with EMMPRIN-enriched membrane vesicles. UPA expression was analyzed by qPCR and immunostaining and the consequence on the invasion capacity was studied using modified Boyden chamber assay, in the presence or absence of EMMPRIN blocking antibody, the uPA inhibitor amiloride or the MMP inhibitor marimastat., Results: OSCC tumors were shown to express more EMMPRIN and uPA compared to dysplastic lesions. The corresponding cell models, SCC-9 and DOK cells, displayed similar expression pattern. In both cell types EMMPRIN upregulated the expression of uPA as well as that of MMP-2 and MMP-9. EMMPRIN treatment led to a significant increase in cell invasion both in the invasive SCC-9 and in the less invasive dysplastic DOK cells, in an MMP and uPA dependent manner., Conclusions: Our results suggest that the upregulation of uPA contributes to EMMPRIN's effect in promoting oral tumor invasion.
- Published
- 2012
- Full Text
- View/download PDF
32. Distinct expression patterns of the E3 ligase SIAH-1 and its partner Kid/KIF22 in normal tissues and in the breast tumoral processes.
- Author
-
Bruzzoni-Giovanelli H, Fernandez P, Veiga L, Podgorniak MP, Powell DJ, Candeias MM, Mourah S, Calvo F, and Marín M
- Subjects
- Adult, Aged, Aged, 80 and over, Cell Line, Tumor, Female, Humans, Middle Aged, Nuclear Proteins genetics, RNA, Messenger metabolism, Breast metabolism, Breast Neoplasms genetics, Breast Neoplasms metabolism, DNA-Binding Proteins metabolism, Kinesins metabolism, Nuclear Proteins metabolism, Ubiquitin-Protein Ligases genetics, Ubiquitin-Protein Ligases metabolism
- Abstract
SIAH proteins are the human members of an highly conserved family of E3 ubiquitin ligases. Several data suggest that SIAH proteins may have a role in tumor suppression and apoptosis. Previously, we reported that SIAH-1 induces the degradation of Kid (KIF22), a chromokinesin protein implicated in the normal progression of mitosis and meiosis, by the ubiquitin proteasome pathway. In human breast cancer cells stably transfected with SIAH-1, Kid/KIF22 protein level was markedly reduced whereas, the Kid/KIF22 mRNA level was increased. This interaction has been further elucidated through analyzing SIAH and Kid/KIF22 expression in both paired normal and tumor tissues and cell lines. It was observed that SIAH-1 protein is widely expressed in different normal tissues, and in cells lines but showing some differences in western blotting profiles. Immunofluorescence microscopy shows that the intracellular distribution of SIAH-1 and Kid/KIF22 appears to be modified in human tumor tissues compared to normal controls. When mRNA expression of SIAH-1 and Kid/KIF22 was analyzed by real-time PCR in normal and cancer breast tissues from the same patient, a large variation in the number of mRNA copies was detected between the different samples. In most cases, SIAH-1 mRNA is decreased in tumor tissues compared to their normal counterparts. Interestingly, in all breast tumor tissues analyzed, variations in the Kid/KIF22 mRNA levels mirrored those seen with SIAH-1 mRNAs. This concerted variation of SIAH-1 and Kid/KIF22 messengers suggests the existence of an additional level of control than the previously described protein-protein interaction and protein stability regulation. Our observations also underline the need to re-evaluate the results of gene expression obtained by qRT-PCR and relate it to the protein expression and cellular localization when matched normal and tumoral tissues are analyzed.
- Published
- 2010
- Full Text
- View/download PDF
33. Extracellular matrix metalloproteinase inducer up-regulates the urokinase-type plasminogen activator system promoting tumor cell invasion.
- Author
-
Quemener C, Gabison EE, Naïmi B, Lescaille G, Bougatef F, Podgorniak MP, Labarchède G, Lebbé C, Calvo F, Menashi S, and Mourah S
- Subjects
- Animals, Basigin genetics, Breast Neoplasms enzymology, Breast Neoplasms genetics, Cell Line, Tumor, Humans, Metalloproteases metabolism, Mice, Mice, Nude, Neoplasm Invasiveness, Plasminogen Activator Inhibitor 1 biosynthesis, Plasminogen Activator Inhibitor 1 genetics, Receptors, Cell Surface biosynthesis, Receptors, Cell Surface genetics, Receptors, Urokinase Plasminogen Activator, Transfection, Up-Regulation, Urokinase-Type Plasminogen Activator genetics, Basigin metabolism, Breast Neoplasms metabolism, Breast Neoplasms pathology, Urokinase-Type Plasminogen Activator biosynthesis
- Abstract
Extracellular matrix metalloproteinase inducer (EMMPRIN) is a membrane glycoprotein overexpressed in many cancer tissues and is known for its ability to stimulate MMP expression. In this work, we show that EMMPRIN is also a regulator of the urokinase-type plasminogen activation (uPA) system of serine proteases, thus participating to the increase of the overall proteolytic function of the cancer cells. Enhanced EMMPRIN expression in a tumorigenic breast epithelial cell line NS2T2A increased the levels of uPA, uPA receptor, and the uPA inhibitor plasminogen activator inhibitor-1 (PAI-1), as measured by quantitative reverse transcription-PCR, Western blot, and plasminogen-casein zymography. This response was down-regulated by either EMMPRIN small interfering RNA or a blocking antibody to EMMPRIN. EMMPRIN-containing purified membrane fraction from Chinese hamster ovary cells when added exogenously to NS2T2A cells induced a similar activation of the uPA/PAI-1 system. Additionally, overexpression of EMMPRIN in NS2T2A cells increased uPA levels in cocultured endothelial cells, showing a paracrine regulation loop involving a tumor-stroma interaction. EMMPRIN-expressing cells also exhibited enhanced invasive potential in vitro, and the use of amiloride (uPA inhibitor) and marimastat (MMP inhibitor) showed that the two proteolytic systems reduced alone and in combination the invasive potential mediated through EMMPRIN. These data show a novel regulatory pathway for uPA activity and suggest that EMMPRIN is involved in uPA dysregulation observed in cancer.
- Published
- 2007
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.